Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
7
Frequently Asked Questions
What is Market Cap of Matinas Biopharma Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Matinas Biopharma Holdings Inc market cap is $8.24M.
What is the 52-week high for Matinas Biopharma Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Matinas Biopharma Holdings Inc 52 week high is $4.25 as of September 12, 2025.
What is the 52-week low for Matinas Biopharma Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Matinas Biopharma Holdings Inc 52 week low is $0.4748 as of September 12, 2025.
What is Matinas Biopharma Holdings Inc stock price today?
Matinas Biopharma Holdings Inc stock price today is $1.80.
What was Matinas Biopharma Holdings Inc stock price yesterday?
Matinas Biopharma Holdings Inc stock price yesterday was $1.62.
What is the PE ratio of Matinas Biopharma Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Matinas Biopharma Holdings Inc’s P/E ratio is -0.42.
What is the Price-to-Book ratio of Matinas Biopharma Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Matinas Biopharma Holdings Inc P/B ratio is 1.0737.
What is the 50-day moving average of Matinas Biopharma Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Matinas Biopharma Holdings Inc 50-day moving average is $1.33.
How many employess does Matinas Biopharma Holdings Inc has?